Cargando…
Protective potential of piroxicam on human peripheral blood mononuclear cells against the suppressive capacity of glioblastoma cell lines
Dexamethasone, a common medication used in the treatment regimen of glioblastoma, has broad inhibitory effects on the immune responses. Here, in an in vitro study, we examined the effects of piroxicam, a potent substitute for dexamethasone, on peripheral blood mononuclear cells (PBMCs) co-cultured w...
Autores principales: | Abdesheikhi, Jahangir, Sedghy, Farnaz, Farsinejad, Alireza, Mahmoudi, Merat, ranjkesh, Mahdi, Ahmadi-Zeidabadi, Meysam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9672323/ https://www.ncbi.nlm.nih.gov/pubmed/36396965 http://dx.doi.org/10.1038/s41598-022-24392-2 |
Ejemplares similares
-
Metabolic Regulation of T cell Activity: Implications for Metabolic-Based T-cell Therapies for Cancer
por: Abdesheikhi, Jahangir, et al.
Publicado: (2023) -
Piroxicam-β-Cyclodextrin: A GI Safer Piroxicam
por: Scarpignato, C
Publicado: (2013) -
Effect of Piroxicam on ART Outcome: A Pilot Study
por: Sohrabvand, Farnaz, et al.
Publicado: (2014) -
In vitro evaluation of decontamination effects on mechanical properties of fibrin membrane
por: Akbari Saeed, Taher, et al.
Publicado: (2018) -
Moderate Exercise Enhances the Production of Interferon-γ and Interleukin-12 in Peripheral Blood Mononuclear Cells
por: Zamani, Alireza, et al.
Publicado: (2017)